Immuno-Cell Therapy Market

Immuno-Cell Therapy is known as a systemic treatment with minimal adverse reaction in cancer treatment. Basic concept of the therapy is to strengthen immune function of human body for elimination of any abnormal cells such as virus-infected or malignant cells from the body.

Immuno-Cell Therapy Market contains market size and forecasts of Immuno-Cell Therapy in Global, including the following market information:

• Global Immuno-Cell Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Immuno-Cell Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Passive Immune (NK, LAK etc) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Immuno-Cell Therapy include MEDINET Co, Erytech, Seta Clinic Group, Takeda, SBI Holdings, Oxford BioTherapeutics, Fate Therapeutics, Gilead Sciences and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

surveyed the Immuno-Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Immuno-Cell Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Immuno-Cell Therapy Market Segment Percentages, by Type, 2021 (%)

• Passive Immune (NK, LAK etc)
• Active Immune

Global Immuno-Cell Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Immuno-Cell Therapy Market Segment Percentages, by Application, 2021 (%)

• Oncology
• Cardiovascular Disease (CVD)
• Orthopedic
• Wound Healing
• Others

Global Immuno-Cell Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Immuno-Cell Therapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Immuno-Cell Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Immuno-Cell Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• MEDINET Co
• Erytech
• Seta Clinic Group
• Takeda
• SBI Holdings
• Oxford BioTherapeutics
• Fate Therapeutics
• Gilead Sciences
• Novartis
• Osiris
• Vericel Corporation
• Fujifilm Cellular Dynamics
• JCR Pharmaceuticals
• Beike Biotechnology
• Golden Meditech
• Guanhao Biotech
• Beroni Group